Prenosis reposted this
LifeBridge Health's Sinai Hospital of Baltimore is putting Prenosis' AI-powered diagnostic for sepsis into clinical use, bringing a research-backed tool to the patients' bedside https://lnkd.in/etngFpjV
Prenosis is transforming clinical diagnosis with artificial intelligence that leverages holistic molecular and clinical data.
External link for Prenosis
3440 S Dearborn St
Chicago, Illinois 60616, US
Prenosis reposted this
LifeBridge Health's Sinai Hospital of Baltimore is putting Prenosis' AI-powered diagnostic for sepsis into clinical use, bringing a research-backed tool to the patients' bedside https://lnkd.in/etngFpjV
We're one step closer to precision medicine for acute care. Today's article in Fierce Healthcare discusses how Prenosis' FDA-authorized sepsis AI tool is deployed for clinical use at LifeBridge Health's Sinai Hospital of Baltimore. Sinai Hospital's research team contributed to the foundational study behind the FDA authorization of Sepsis ImmunoScore®. Now, their clinical teams are putting it to use at the bedside to speed sepsis detection. "I'm excited about the potential of AI to revolutionize this particular problem, which is about understanding the complex biology of these patients, so that the right patient can be matched to the right treatment at the right time," says Bobby Reddy, Jr., PhD, CEO and co-founder of Prenosis. Read the full article 👉 https://lnkd.in/etngFpjV Martin Gesheff | Charles R. Albrecht III | Greg Corcoran, MD #Sepsis #HealthTech #AI #PrecisionMedicine #SeePeopleDifferently #SepsisImmunoScore
At Prenosis, we've always believed that trust, not just performance, is what determines whether AI actually transforms care. That belief comes from our core values: doing things right, and building trust through transparency at every step, especially in tools designed for clinical use. In our eBook on responsible AI, we've distilled that thinking into a framework for trustworthy AI in healthcare, built on three pillars to drive clinical adoption: 1️⃣ external validation, 2️⃣ transparency and model insight, and 3️⃣ continuous performance monitoring. The eBook also covers the core principles for use of AI in healthcare: fairness and algorithmic equity, explainability, and alignment with human values, along with a section on what it takes to govern AI responsibly inside a healthcare organization. Check out our eBook: https://lnkd.in/eGK6R-HU #AIinHealthcare #AIGovernance #SeePeopleDifferently
Precision medicine revolutionized oncology, but acute care hasn't seen that same transformation. Until now. In this on-demand webinar, Prenosis CEO and co-founder Bobby Reddy, Jr., PhD sits down with Healthcare Innovation content editor, Melinda Taschetta-Millane, to unpack why acute care has lagged behind and what's finally changing. A preview of what you'll hear: ✅ How the convergence of AI, real-time biological profiling, and historic FDA momentum is transforming critical care ✅ Why patient stratification is at the root of failed trials in this space, and how real-time biological profiling with Prenosis's precision medicine platform can help ✅ What FDA authorization of AI diagnostic tools means for the future of AI-driven technology ✅ Where precision medicine in acute care goes from here Access the webinar on-demand here: https://lnkd.in/e4G-jHG2 #AIinHealthcare #PrecisionMedicine #AI #AcuteCare #HealthTech #CriticalCare #HealthcareInnovation #MedTech
#ICYMI Research published in Diagnostics MDPI shows that Sepsis ImmunoScore® significantly outperforms six widely used clinical scores and biomarkers — including SOFA, procalcitonin, and NEWS — for predicting sepsis, in-hospital mortality, and ICU admission. In a multicenter study of more than 6,000 adult patients across 7 U.S. hospital sites, the Sepsis ImmunoScore achieved: 📊 AUC of 0.82 for sepsis prediction 📊 AUC of 0.80 for in-hospital mortality prediction 📊 AUC of 0.74 for ICU admission prediction All outperforming SOFA, PCT, CRP, SIRS, NEWS, and qSOFA, with statistically significant differences across every outcome. 🔗 Read the full study → https://lnkd.in/eTPgHDDc #Sepsis #PrecisionMedicine #HealthcareAI #ClinicalDecisionSupport #SepsisImmunoScore #SeePeopleDifferently Gregory Watson Lincoln Updike Carlos Lopez-Espina Akhil Bhargava Lee Schmalz Shah Khan Dennys U. Rashid Bashir Nate Shapiro MD, MPH Bobby Reddy, Jr.
The 2026 Association for Diagnostics & Laboratory Medicine Data Science Symposium is coming up in a couple of weeks! Prenosis is once again proud to sponsor this year's event in Anaheim on July 30. Focused on delivering value with laboratory data science, the symposium includes a panel discussion on regulatory and quality compliance in laboratory medicine AI. 👇 For more information https://lnkd.in/ezEayKJb #ADLM #HealthcareInnovation #Diagnostics
📣 Our very own Akhil Bhargava is speaking to members of the The Ohio Hospital Association tomorrow on the topic of "Precision Medicine in Sepsis." 🩸 On the webinar, we'll discuss the role of AI-derived biomarkers and technology platforms in enhancing sepsis identification and clinical decision-making. 🏥 This event is free for OHA members, and ideal for RNs, case managers, sepsis coordinators/champions, ED staff and leadership, patient care staff, patient advocates/liaisons, risk managers, quality and patient safety staff, CNOs, and CMOs. 📅 Wednesday, July 15 ⏰ 10:30am-11:30am CT / 11:30am-12:30pm ET 👇 Registration info https://lnkd.in/eUaXfGNz #SepsisCare #AI #AIBiomarkers #AIforHealthcare #Prenosis #SeePeopleDifferently
#ICYMI: Prenosis CEO Bobby Reddy, Jr. spoke with Khullani A. on the AI in Chicago Podcast. Their conversation sheds light on the challenges of building healthcare AI, underscored by the long road to the development of Sepsis ImmunoScore®. Check out the interview 👉 https://lnkd.in/ek7Br7fm #AIinHealthcare #Sepsis #SeePeopleDifferently #PrecisionMedicine
#TBT: As part of Labcorp Knowledge Library's series "Brief interviews with healthcare innovators," James Almas, M.D., interviewed Bobby Reddy, Jr. on Prenosis' mission to transform sepsis care with AI. Labcorp honors their commitment to advance personalized care and research across health systems by investing in Prenosis and other trailblazing companies to help them scale. Check out the interview 👉 https://lnkd.in/etNZuMgh #AIinHealthcare #HealthcareInnovation #SepsisCare #ClinicalAI #SeePeopleDifferently
#ICYMI: Our CEO Bobby Reddy, Jr. shared with his alma mater, The Grainger College of Engineering, about his entrepreneurial call to solve gaps in healthcare that led to the founding of Prenosis. Read on for the full story 👇 https://lnkd.in/gEsZp5hB #Prenosis #PrecisionMedicine #AcuteCare #SeePeopleDifferently